Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,482,326
  • Shares Outstanding, K 154,409
  • Annual Sales, $ 90,890 K
  • Annual Income, $ -84,130 K
  • 60-Month Beta 2.03
  • Price/Sales 15.71
  • Price/Cash Flow N/A
  • Price/Book 34.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.15
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +26.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.82 +68.33%
on 09/04/20
9.95 -1.46%
on 09/29/20
+3.40 (+52.96%)
since 08/28/20
3-Month
3.41 +187.54%
on 07/01/20
9.95 -1.46%
on 09/29/20
+6.36 (+184.20%)
since 06/29/20
52-Week
2.20 +345.68%
on 03/18/20
9.95 -1.46%
on 09/29/20
+4.59 (+87.84%)
since 09/27/19

Most Recent Stories

More News
Pacific Biosciences (PACB) Looks Good: Stock Adds 5.3% in Session

Pacific Biosciences (PACB) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

HOLX : 66.07 (+0.46%)
PACB : 9.89 (+3.02%)
Pacific Biosciences' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Pacific Biosciences of California.

PACB : 9.89 (+3.02%)
Pacific Biosciences Announces New Chief Financial Officer

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief...

PACB : 9.89 (+3.02%)
Pacific Bioscien Up 82.6% Since SmarTrend Uptrend Call (PACB)

SmarTrend identified an Uptrend for Pacific Bioscien (NASDAQ:PACB) on March 26th, 2020 at $3.39. In approximately 5 months, Pacific Bioscien has returned 82.57% as of today's recent price of $6.18.

PACB : 9.89 (+3.02%)
Pacific Biosciences (PACB) Up 82.4% Since Last Earnings Report: Can It Continue?

Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PACB : 9.89 (+3.02%)
Pacific Biosciences (PACB) Catches Eye: Stock Jumps 6.6%

Pacific Biosciences (PACB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

HOLX : 66.07 (+0.46%)
PACB : 9.89 (+3.02%)
Uptrend Call Working As Pacific Bioscien Stock Rises 81.2% (PACB)

SmarTrend identified an Uptrend for Pacific Bioscien (NASDAQ:PACB) on March 26th, 2020 at $3.39. In approximately 5 months, Pacific Bioscien has returned 81.24% as of today's recent price of $6.14.

PACB : 9.89 (+3.02%)
Watch for Pacific Bioscien to Potentially Pullback After Gaining 21.03% Yesterday

Pacific Bioscien (NASDAQ:PACB) traded in a range yesterday that spanned from a low of $5.07 to a high of $5.78. Yesterday, the shares gained 21.0%, which took the trading range above the 3-day high of...

PACB : 9.89 (+3.02%)
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock

Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("Pacific Biosciences" or the "Company") today announced that it has priced its previously announced underwritten public offering of 19,430,000 shares...

MS : 47.38 (-2.07%)
PACB : 9.89 (+3.02%)
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering. Pacific Biosciences...

MS : 47.38 (-2.07%)
PACB : 9.89 (+3.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade PACB with:

Business Summary

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed...

See More

Key Turning Points

2nd Resistance Point 10.04
1st Resistance Point 9.82
Last Price 9.89
1st Support Level 9.20
2nd Support Level 8.81

See More

52-Week High 9.95
Last Price 9.89
Fibonacci 61.8% 6.99
Fibonacci 50% 6.07
Fibonacci 38.2% 5.16
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar